Showing results (11-20 of 224) with videos related to
Sort By:
Pageof 23
Mass Spectrometry Reviews|July 13, 2010
Mass spectrometry in the quantitative analysis of therapeutic intracellular nucleotide analogsRobert S Jansen, Hilde Rosing, Jan H M Schellens, et al.Biomedical Chromatography : BMC|October 8, 2022
Bioanalytical methods for pharmacokinetic studies of antileishmanial drugsIgnace C Roseboom, Hilde Rosing, Jos H Beijnen, et al.Fundamental & Clinical Pharmacology|March 5, 2010
Deoxyuridine analog nucleotides in deoxycytidine analog treatment: secondary active metabolites?Robert S Jansen, Hilde Rosing, Jan H M Schellens, et al.Journal of Pharmaceutical and Biomedical Analysis|October 3, 2020
Skin tissue sample collection, sample homogenization, and analyte extraction strategies for liquid chromatographic mass spectrometry quantification of pharmaceutical compoundsIgnace C Roseboom, Hilde Rosing, Jos H Beijnen, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 16, 2003
Simple and rapid method for the simultaneous determination of the non-nucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma using liquid chromatographyBregt S Kappelhoff, Hilde Rosing, Alwin D R Huitema, et al.Biomedical Chromatography : BMC|August 4, 2009
A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasmaLiia D Vainchtein, Hilde Rosing, Jan H M Schellens, et al.Rapid Communications in Mass Spectrometry : RCM|August 26, 2009
Simultaneous quantification of 2',2'-difluorodeoxycytidine and 2',2'-difluorodeoxyuridine nucleosides and nucleotides in white blood cells using porous graphitic carbon chromatography coupled with tandem mass spectrometryRobert S Jansen, Hilde Rosing, Jan H M Schellens, et al.Bioanalysis|December 6, 2011
Bioanalytical aspects of clinical mass balance studies in oncologyAnne-Charlotte Dubbelman, Hilde Rosing, Jan H M Schellens, et al.Biomedical Chromatography : BMC|June 20, 2019
Bioanalytical LC-MS/MS validation of therapeutic drug monitoring assays in oncologyMerel van Nuland, Hilde Rosing, Jan H M Schellens, et al.Clinical Chemistry and Laboratory Medicine|May 21, 2010
A less sensitive detector does not necessarily result in a less sensitive method: fast quantification of 13 antiretroviral analytes in plasma with liquid chromatography coupled with tandem mass spectrometryRob Ter Heine, Hilde Rosing, Jos H Beijnen, et al.Pageof 23